Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LOEWS CORPL · Entity 3231 | DIRECTOR EMERITUS | June 30, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LOEWS CORP
Report date June 30, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,165 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Grant · Acquired 102 · Balance 22,165 F1: Represents quarterly grant of common stock in respect of director compensation (prorated for service through the date of his retirement as a director) under the Loews Corporation 2025 Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents quarterly grant of common stock in respect of director compensation (prorated for service through the date of his retirement as a director) under the Loews Corporation 2025 Incentive Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CANTEL MEDICAL CORP
Report date June 02, 2021 · Filed June 02, 2021
Section 16 reporting ended · disclosed 2021-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-02 transaction · row 1
1 source rowRow 1 · 2021-06-02 · Disposition to issuer · Disposed 2,865,637 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectBy wife | 0 |
Reported balance
After 2021-06-02 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-06-02 · Disposition to issuer · Disposed 374,112 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectBy custodial accounts for benefit of grandchildren | 0 |
Reported balance
After 2021-06-02 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-06-02 · Disposition to issuer · Disposed 185,928 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectShares held by Dico Group, Inc. | 0 |
Reported balance
After 2021-06-02 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-06-02 · Disposition to issuer · Disposed 29,430 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration").
F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2018 Filed Mar 2, 2018 21:19 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $40.34 | $0.00 |
DisclosureSEC source: 0001140361-18-011634 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2018-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:19 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 274 | $49.38 | $13,530.12 |
DisclosureSEC source: 0001140361-18-011634 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,534 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $49.34 and $49.39. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:19 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,226 | $49.34 | $60,490.84 |
DisclosureSEC source: 0001140361-18-011634 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,808 Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:19 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $40.34 | $60,510.00 |
DisclosureSEC source: 0001140361-18-011634 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 18:23 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 10,000 | $110.96 | $1,109,564.00 |
DisclosureSEC source: 0000019446-18-000007 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,036,978 F1 · price: The per share prices ranged from $110.35 to $111.30. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 11, 2018 Filed Jan 11, 2018 16:05 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 5,700 | $107.26 | $611,367.75 |
DisclosureSEC source: 0000019446-18-000006 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,046,978 F2 · price: The per share prices ranged from $107.00 to $108.05. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 09, 2018 Filed Jan 11, 2018 16:05 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 4,278 | $107.05 | $457,977.44 |
DisclosureSEC source: 0000019446-18-000006 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,052,678 F1 · price: The per share prices ranged from $107.00 to $107.26. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 27, 2017 Filed Dec 27, 2017 12:44 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 3,000 | $102.42 | $307,263.00 |
DisclosureSEC source: 0000019446-17-000075 · edgar.xml · nonDerivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,056,956 F4 · price: The per share prices ranged from $102.25. to $102.60. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 26, 2017 Filed Dec 27, 2017 12:44 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,040 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000075 · edgar.xml · nonDerivative · entry 7 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By custodial accounts for benefit of grandchildren Disclosed balance after: 86,494 Read SEC document |
| December 26, 2017 Filed Dec 27, 2017 12:44 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000075 · edgar.xml · nonDerivative · entry 5 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 452,238 Read SEC document |
| December 26, 2017 Filed Dec 27, 2017 12:44 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000075 · edgar.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,059,956 Read SEC document |
| December 26, 2017 Filed Dec 27, 2017 12:44 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 5,000 | $102.10 | $510,509.50 |
DisclosureSEC source: 0000019446-17-000075 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,061,256 F2 · price: The per share prices ranged from $102.00. to $102.30. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 22, 2017 Filed Dec 27, 2017 12:44 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 10,000 | $101.10 | $1,011,022.00 |
DisclosureSEC source: 0000019446-17-000075 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,066,256 F1 · price: The per share prices ranged from $100.80 to $101.755. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 19, 2017 Filed Dec 20, 2017 18:38 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 2,000 | $100.43 | $200,859.80 |
DisclosureSEC source: 0000019446-17-000073 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,076,256 F2 · price: The per share prices ranged from $100.10 to $100.75. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 18:38 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 10,000 | $100.54 | $1,005,447.00 |
DisclosureSEC source: 0000019446-17-000073 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,078,256 F1 · price: The per share prices ranged from $100.20 to $101.25. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 14:44 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.7 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-046138 · doc1.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,139.3 Underlying: Common Stock · 2.7 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 14:53 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $49.42 | $0.00 |
DisclosureSEC source: 0001140361-17-044974 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2017-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 14:53 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 32 | $50.07 | $1,602.24 |
DisclosureSEC source: 0001140361-17-044974 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,534 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $49.94 and $50.48. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 14:53 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,468 | $50.48 | $74,104.64 |
DisclosureSEC source: 0001140361-17-044974 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,566 Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 14:53 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $49.42 | $74,130.00 |
DisclosureSEC source: 0001140361-17-044974 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2017 Filed Dec 27, 2017 12:44 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | OtherCommon Stock, par value $.10 per share | 106,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000075 · edgar.xml · nonDerivative · entry 6 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By trust for benefit of children Disclosed balance after: 108,271 F3 · kind: Transfer of shares from trust to a beneficiary of the trust Read SEC document |
| October 18, 2017 Filed Nov 3, 2017 07:50 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 613 | $95.42 | $58,492.46 |
DisclosureSEC source: 0000019446-17-000059 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,088,256 Read SEC document |
| October 10, 2017 Filed Oct 12, 2017 14:19 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GrantCommon Stock, par value $.10 per share | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000047 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,088,869 Read SEC document |
| October 04, 2017 Filed Oct 4, 2017 17:06 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 20,500 | $99.15 | $2,032,538.10 |
DisclosureSEC source: 0000019446-17-000038 · edgar.xml · nonDerivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,087,569 F1 · price: The per share prices ranged from $98.75 to $99.45. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 03, 2017 Filed Oct 4, 2017 17:06 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | OtherCommon Stock, par value $.10 per share | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000038 · edgar.xml · nonDerivative · entry 6 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By trust for benefit of children Disclosed balance after: 214,271 F2 · kind: Transfer of shares from trust to a beneficiary of the trust Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 17:06 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Exercise / conversionCommon Stock, par value $.10 per share · Derivative | 52,500 | $0.00 Strike: $17.04 | $0.00 |
DisclosureSEC source: 0000019446-17-000038 · edgar.xml · derivative · entry 9 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $.10 per share · 52,500 shares Expires 2017-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The per share prices ranged from $98.75 to $99.45. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 17:06 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 22,452 | $94.17 | $2,114,304.84 |
DisclosureSEC source: 0000019446-17-000038 · edgar.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,108,069 Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 17:06 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 9,499 | $94.17 | $894,520.83 |
DisclosureSEC source: 0000019446-17-000038 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,130,521 Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 17:06 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Exercise / conversionCommon Stock, par value $.10 per share | 52,500 | $17.04 | $894,600.00 |
DisclosureSEC source: 0000019446-17-000038 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,140,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2017 Filed Oct 4, 2017 17:06 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000038 · edgar.xml · nonDerivative · entry 5 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 453,538 Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 18:07 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-035478 · doc1.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,136.6 Underlying: Common Stock · 2.8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| July 12, 2017 Filed Jul 12, 2017 17:19 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 14,000 | $75.48 | $1,056,701.80 |
DisclosureSEC source: 0000019446-17-000021 · edgar.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,087,520 F3 · price: The per share prices ranged from $75.25 to $76.00. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 17:19 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 13,000 | $75.55 | $982,198.10 |
DisclosureSEC source: 0000019446-17-000021 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,101,520 F2 · price: The per share prices ranged from $75.10 to $76.045. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 17:19 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 8,000 | $75.53 | $604,256.00 |
DisclosureSEC source: 0000019446-17-000021 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,114,520 F1 · price: The per share prices ranged from $75.00 to $75.835. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 17:11 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-025103 · doc1.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,133.8 Underlying: Common Stock · 2.8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 17:01 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 1,702 | $76.02 | $129,385.19 |
DisclosureSEC source: 0000019446-17-000016 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,122,520 F2 · price: The per share prices ranged from $76.00 to $76.07. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 17:01 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 11,298 | $76.41 | $863,271.14 |
DisclosureSEC source: 0000019446-17-000016 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,124,222 F1 · price: The per share prices ranged from $76.10 to $76.79. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 10, 2017 Filed May 11, 2017 17:11 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 2,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019584 · doc1.xml · derivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,534 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units (each, an "RSU") convert into shares of common stock on a one-for-one basis. F4 · derivative.exercise_date: On May 10, 2016, the Reporting Person was granted 2,520 RSUs, which, together with 14 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the 2016 RSUs, vest on the first anniversary of the grant date. F4 · derivative.expiration_date: On May 10, 2016, the Reporting Person was granted 2,520 RSUs, which, together with 14 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the 2016 RSUs, vest on the first anniversary of the grant date. Read SEC document |
| May 10, 2017 Filed May 11, 2017 17:11 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-019584 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units (each, an "RSU") convert into shares of common stock on a one-for-one basis. Read SEC document |
| May 09, 2017 Filed May 11, 2017 17:11 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019584 · doc1.xml · derivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,131 Underlying: Common Stock · 2,131 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 9, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 9, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 17:05 UTC | CANTEL MEDICAL CORP CMN · Entity 138805 | SaleCommon Stock, par value $.10 per share | 17,000 | $79.99 | $1,359,892.90 |
DisclosureSEC source: 0000019446-17-000013 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,135,520 F1 · price: The per share prices ranged from $79.75 to $80.50 Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 19:52 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3.4 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-012090 · doc1.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,534.5 Underlying: Common Stock · 3.4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously awarded RSUs (the "Previous RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:39 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $45.75 | $0.00 |
DisclosureSEC source: 0001140361-17-010296 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2017-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:39 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 58 | $47.62 | $2,761.96 |
DisclosureSEC source: 0001140361-17-010296 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $47.57 and $47.63. the Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:39 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,442 | $47.57 | $68,595.94 |
DisclosureSEC source: 0001140361-17-010296 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,058 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:39 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $45.75 | $68,625.00 |
DisclosureSEC source: 0001140361-17-010296 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2016 Filed Jan 25, 2017 16:50 UTC | CANTEL MEDICAL CORP CMN · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000009 · edgar.xml · nonDerivative · entry 7 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By custodial accounts for benefit of grandchildren Disclosed balance after: 85,454 Read SEC document |
| December 22, 2016 Filed Jan 25, 2017 16:50 UTC | CANTEL MEDICAL CORP CMN · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000009 · edgar.xml · nonDerivative · entry 6 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 455,538 Read SEC document |
| December 22, 2016 Filed Jan 25, 2017 16:50 UTC | CANTEL MEDICAL CORP CMN · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000009 · edgar.xml · nonDerivative · entry 5 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,152,520 Read SEC document |
| December 22, 2016 Filed Jan 25, 2017 16:50 UTC | CANTEL MEDICAL CORP CMN · Entity 138805 | GiftCommon Stock, par value $.10 per share | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-17-000009 · edgar.xml · nonDerivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,154,270 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.